China and India will continue to dominate DR issuance from Asia, but issuers from new markets like Vietnam and Mongolia are also likely to emerge, the bank says in a report.
Gregory Roath replaces Chris Kearns who has relocated to New York to focus on global business strategy and product development and to take up a position as deputy CEO of BNY Mellon's DR business.